Sverige rustar för influensapandemi

Socialstyrelsen ser nu över distributionsvägarna för läkemedel med anledning av det uppgraderade beredskapsläget för svininfluensa i världen. Det kan uppstå en brist på vaccin men gemene man behöver inte vara orolig enligt Socialstyrelsen.

Tungviktare till Uppsalabolag

Tikomeds styrelse får ett riktigt proffs med i styrelsen.

Antikropp kan stoppa bröstcancer

Bavarian Nordic rapporterar positiva resultat från fas II-studien av ett nytt bröstcancervaccin.

Avhopp i Probis top

Bolagets styrelseordförande lämnar sitt uppdrag.

Acronordic öppnar Stockholmskontor

CRO-företaget vill expandera ut i hela Norden. En säljspecialist och forskare med bred erfarenhet ska leda det nya kontoret.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

Test if you carry the fat virus

In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Hormones make children fat

A new Danish million project will define the connection between hormons and obesity amongst children.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark

LEO Pharma - International Clinical Trial Manager

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.